Importantly, the oncogenic effects of STAT3 have been well established, and constitutive activation of the STAT3 signaling pathway is essential for survival in several tumor-derived cell lines, including those derived from multiple myeloma [12], astrocytoma [13], in addition to head and neck cancers [14]. This evidence concerns the gene STAT3 and plasma cell myeloma.